Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis

Acta Medica Okayama

Volumn 53, Issue 3, 1999, Pages 123-126

  Oguz, Halit ^a   Bitiren, Muharrem ^a   Aslan, Osman Sevki ^b   Ozardali, Ilyas ^a  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Inflammatory cells; Lodoxamide; Tear; Vernal conjunctivitis

Indexed keywords

ANTIALLERGIC AGENT; DRUG DERIVATIVE; LODOXAMIDE ETHYL; OXAMIC ACID;

ADOLESCENT; ADULT; ALLERGIC CONJUNCTIVITIS; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INFLAMMATION; LACRIMAL FLUID; MALE; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTI-ALLERGIC AGENTS; CHILD; CONJUNCTIVITIS, ALLERGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; MALE; OXAMIC ACID; TEARS;

EID: 0033146277     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Allansmith MR, Baird RS and Griener JV: Vernal conjunctivitis and contact lens-associated giant papillary conjunctivitis compared and contrasted. Am J Ophthalmol (1979) 87, 544-555.
2. Bonini ST, Bonini SE, Allansmith MR, Schiavone M, Berruto A, Centofanti M and Bucci MG: Topical histamine testing for conjunctival hyperreactivity in vernal conjunctivitis. Invest Ophthalmol Vis Sci (1989) 30, 503.
3. Buckley RJ: Vernal keratoconjunctivitis. Int Ophthalmol Clin (1988) 28, 303-308.
4. Santos CI, Huang AJ, Abelson MB, Foster CS, Friedlander M and McCulley JP: Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis. Am J Ophthalmol (1994) 117, 488-497.
5. Caldwell DR, Verin P, Hartwich-Young R, Meyer SM and Drake MM: Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Am J Ophthalmol (1992) 113, 632-637.
6. Yanni JM, Weimer LK, Glaser RL, Lang LS, Robertson SM and Spellman JM: Effect of lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats. Int Arch Allergy Immunol (1993) 101, 102-106.
7. Bonini S, Schavone M, Bonini S, Magrini L, Lischetti P, Lambiase A and Bucci MG: Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis. Ophthalmology (1997) 104, 849-853.
8. Udell U, Gleich GJ, Allansmith MR, Ackerman SJ and Abelson MB: Eosinophil granule major basic protein and charcot-leyden crystal protein in human tears. Am J Ophthalmol (1981) 92, 824-828.
9. Abelson MB, Madiwale N and Weston JH: Conjunctival eosinophils in allergic ocular disease. Arch Ophthalmol (1983) 101, 555-556.
10. Nomura K, Takamura E, Murata M, Fukagawa K and Uechi K: Quantitative evaluation of inflammatory cells in seasonal allergic conjunctivitis. Ophthalmologica (1997) 211, 1-3.
11. Friedlander MH, Ohashi Y and Kelley J: Diagnosis of allergic conjunctivitis. Arch Ophthalmol (1984) 102, 1198-1199.
12. Akpek EK, Hasiripi H, Albayrak L and Kalayci D: Comparison of the efficacy and safety of lodoxamide and cromolyn sodium in the treatment of seasonal and perennial allergic conjunctivitis. T Klin J Ophthalmol (1996) 5, 117-122.